Phenylbutazone (Canada)

Manufacturer: Vétoquinol

Sterile Injection, Usp

DIN 00596701

Veterinary Use Only

Warning

This drug must not be used in horses that are to be slaughtered for use in food.

Active Ingredient

Phenylbutazone 200 mg/mL.

Preservative

Parachlorometacresol 0.2%W/V.

Phenylbutazone Indications

DOG: As an aid in the treatment of bursitis, osteoarthritis, arthritis, posterior weakness, posterior paralysis, rheumatism, inflammation of skin and other soft tissues.

HORSE: As an aid in the treatment of osteoarthritis of medial and distal bones of the hock, arthritis of the stifle and hip, arthritis of spine, chronic hip pains, chronic pain in trapezius muscles and generalized arthritis.

Dosage

Inject slowly, intravenously.

DOG: 0.5 mL (100 mg) per 5 kg of body weight daily. Total daily dosage should not exceed 4 mL, regardless of weight. Do not treat intravenously for more than 2 consecutive days.

HORSE: 2.5 to 5 mL (0.5 to 1 g) per 250 kg of body weight daily. Total daily dosage should not exceed 20 mL, regardless of weight. Do not treat intravenously for more than 5 consecutive days.

Contraindication

Do not administer to animals with cardiac, renal or hepatic disease or those with evidence of hemocytological disorders.

Phenylbutazone Caution

Once the condition has regressed, treat strictly as required or as recommended by a veterinarian. If no response is noted within 5 days, the treatment should be discontinued and the diagnosis should be reevaluated. Care should be taken to avoid perivascular administration due to possible swelling, necrosis and sloughing at the injection site. Stop medication at first sign of gastrointestinal upsets, jaundice or blood dyscrasia. When inflammatory conditions are caused by microorganisms, adequate therapy should be given simultaneously with phenylbutazone.

Storage

Store between 15° and 25 °C. Protect from freezing.

Vétoquinol N.-A. Inc., 2000, ch. Georges, Lavaltrie, QC, Canada J5T 3S5

Nac No.

12340465